Raymond James Financial Inc. Purchases Shares of 17,725 SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)
Raymond James Financial Inc. acquired a new position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 17,725 shares of the company’s stock, valued at approximately $762,000. Several other hedge funds and other institutional investors have also modified […]
Raymond James Financial Inc. acquired a new position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 17,725 shares of the company’s stock, valued at approximately $762,000. Several other hedge funds and other institutional investors have also modified […]
